ClinicalTrials.Veeva

Menu

Myval TransAXillary Transcatheter Aortic Valve Replacement Multicenter Clinical Registry (MYVAL-TAX-TAVR)

U

University of Luebeck

Status

Enrolling

Conditions

Aortic Valve Stenosis

Treatments

Other: transaxillary (TAX) transcatheter aortic valve replacement

Study type

Observational

Funder types

Other

Identifiers

NCT06493994
2024-240

Details and patient eligibility

About

Study goal is to determine the feasibility, procedural success, safety and potential benefit of the Myval transcatheter heart valve (THV) in patients undergone transaxillary (TAX) transcatheter aortic valve replacement (TAVR).

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient has been treatet transaxillary (TAX) with Myval transcatheter aortic valve replacement
  • BMI <35 kg/m2
  • Ability to give informed consent

Exclusion criteria

  • History of coronary artery bypass graft and a patent left internal mammary artery (LIMA)
  • Age ≤18 years
  • Patients presenting with pregnancy
  • Patients without informed consent
  • Expected life expectancy <2 years

Trial contacts and locations

1

Loading...

Central trial contact

Ingo Eitel, Prof. Dr.; Roza Saraei, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems